https://www.dlapiper.com/en-jp/news/2024/04/dla-piper-advises-symphar-on-sale-to-pharmaceutical-manufacturer-farmak
DLA Piper advises Symphar on sale to pharmaceutical manufacturer Farmak | DLA Piper
DLA Piper has advised the shareholders of Symphar sp. z o.o., a leading Polish pharmaceutical business, on the sale of 100% of share to Farmak, a global...
dla piperon salepharmaceutical manufactureradvisessymphar